Harmony Biosciences Holdings Inc's Company Valuation
Currency: USD Updated: 2026-06-18
Previous score
8.08
Change
0
The current valuation score of Harmony Biosciences Holdings Inc is 8.08, ranking 106 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 13.17, which is 52.58% below the recent high of 20.09 and 42.26% above the recent low of 7.60.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.